108 related articles for article (PubMed ID: 15993030)
1. Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
Balcerczak E; Pasz-Walczak G; Kumor P; Panczyk M; Kordek R; Wierzbicki R; Mirowski M
Eur J Surg Oncol; 2005 Sep; 31(7):721-6. PubMed ID: 15993030
[TBL] [Abstract][Full Text] [Related]
2. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers.
Oda K; Okabayashi T; Kataoka M; Takeda A; Shibuya Y; Orita K; Tanaka N
Res Commun Mol Pathol Pharmacol; 1999; 105(3):237-52. PubMed ID: 10954128
[TBL] [Abstract][Full Text] [Related]
4. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
5. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
6. [Malignancy of colorectal cancer analyzed by expression of cyclin D1].
Maeda K; Kang SM; Ogawa M; Chung YS; Onoda N; Nakata B; Nishiguchi Y; Ikehara T; Okuno M; Sowa M
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():259-62. PubMed ID: 9263512
[TBL] [Abstract][Full Text] [Related]
7. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
8. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
[TBL] [Abstract][Full Text] [Related]
9. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
10. Expression of the p65 gene in patients with colorectal cancer: comparison with some histological typing, grading and clinical staging.
Balcerczak M; Balcerczak E; Pasz-Walczak G; Kordek R; Mirowski M
Eur J Surg Oncol; 2004 Apr; 30(3):266-70. PubMed ID: 15028307
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
13. [RhoA gene expression in colorectal carcinoma].
Wang H; Chen Y; Cao D; Zhang Y; Meng R; Lu J
Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):348-51. PubMed ID: 11953197
[TBL] [Abstract][Full Text] [Related]
14. High Pin1 expression is associated with tumor progression in colorectal cancer.
Kuramochi J; Arai T; Ikeda S; Kumagai J; Uetake H; Sugihara K
J Surg Oncol; 2006 Aug; 94(2):155-60. PubMed ID: 16847925
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.
Koehler A; Bataille F; Schmid C; Ruemmele P; Waldeck A; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2004 Sep; 204(1):65-74. PubMed ID: 15307139
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
